AI-Generated Summary
Invests in
Sectors:
Locations:
Min Investment:
$1,000,000.00Max Investment:
$5,000,000.00Target Investment:
$1,500,000.00
Skills
Education
- DC
Bachelor of Arts (B.A.)
- NU
Accelerated Master of Business Administration (M.B.A)
- HM
- YS
(2020 - 2020)
- HE
- TT
- Uo
(2012 - 2012)
- Uo
(2011 - 2011)
- MA
(2005 - 2008)
- Pennsylvania Governor's School of Science
(2007 - 2007)
Lists including Nishant
Work Experience
VP, Head of Transactions
2018
New Rhein is an operationally-oriented life sciences investment fund that applies a private equity model to biotech/medtech investing. At the core of New Rhein's strategy is a commitment to actively manage the value creation process. This involves taking substantial stakes in a select number of companies to enable focus on successful product development and commercialization, while mitigating science-based risk. New Rhein's team is comprised of former senior executives from renowned pharmaceutical companies, who bring industry-specific expertise to each deal.
2023
Member Board of Directors
2023
Pulmonary Arterial Hypertension
Board Observer
2023
Metabolic / Obesity Medicine
2020
Board Observer
2020
Benign Prostatic Hyperplasia
2019
Board Observer
2019
Nerve Repair
2020 - 2023
Board Observer
2020 - 2023
Manufacturer of injectable drug products (CDMO / CMO)
2017 - 2018
MBA Intern
2017 - 2018
2017 - 2017
MBA Intern
2017 - 2017
2016 - 2017
Board Observer
2016 - 2017
Minimally Invasive Mechanical Circulatory Support
2016 - 2017
Board Observer
2016 - 2017
Cardiac Telemetry